James R. Bateman

James R. Bateman

Auto-generated profile, based on publicly available information

James R. Bateman

Wake Forest University School of Medicine

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2022 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PDF file
GMGargi Mahapatra
Gargi Mahapatra
ZGZhengrong Gao
Zhengrong Gao
JBJames R. Bateman
James R. Bateman
SLSamuel Neal Lockhart
Samuel Neal Lockhart
JBJaclyn Bergstrom
Jaclyn Bergstrom
AMAnthony J. A. Molina
Anthony J. A. Molina
Introduction: Despite evidence for systemic mitochondrial dysfunction early in Alzheimer's disease (AD) pathogenesis, reliable approaches monitoring these key bioenergetic alterations are lacking. We used peripheral blood mononuclear cells (PBMCs) and platelets as reporters of mitochondrial function in the context of cognitive impairment and AD.Methods: Mitochondrial function was analyzed using complementary respirometric approaches in intact and permeabilized cells from older adults with normal cognition, mild cognitive impairment (MCI), and dementia due to probable AD. Clinical outcomes included measures of cognitive function and brain morphology.Results: PBMC and platelet bioenergetic parameters were lowest in dementia participants. MCI platelets exhibited higher maximal respiration than normocognitives. PBMC and platelet respiration positively associated with cognitive ability and hippocampal volume, and negatively associated with white matter hyperintensities.Discussion: Our findings indicate blood‐based bioenergetic profiling can be used as a minimally invasive approach for measuring systemic bioenergetic differences associated with dementia, and may be used to monitor bioenergetic changes associated with AD risk and progression.Highlights: Peripheral cell bioenergetic alterations accompanied cognitive decline in older adults with mild cognitive impairment (MCI) and Alzheimer's disease (AD) and related dementia (DEM). Peripheral blood mononuclear cells (PBMC) and platelet glucose‐mediated respiration decreased in participants with dementia compared to normocognitive controls (NC). PBMC fatty‐acid oxidation (FAO)‐mediated respiration progressively declined in MCI and AD compared to NC participants, while platelet FAO‐mediated respiration exhibited an inverse‐Warburg effect in MCI compared to NC participants. Positive associations were observed between bioenergetics and Modified Preclinical Alzheimer's Cognitive Composite, and bioenergetics and hippocampal volume %, while a negative association was observed between bioenergetics and white matter hyperintensities. Systemic mitochondrial dysfunction is associated with cognitive decline.

17 January 2014 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
PSPhilip D. Sloane
Philip D. Sloane
CKChristine Kistler
Christine Kistler
CMC. Madeline Mitchell
C. Madeline Mitchell
ABAnna S. Beeber
Anna S. Beeber
RBRosanna M. Bertrand
Rosanna M. Bertrand
SZSheryl Zimmerman
Sheryl Zimmerman

18 December 2018 in Psychosomatics
Verified
Journal Article
Closed access
RNRebekah P. Nash
Rebekah P. Nash
MWMarc S. Weinberg
Marc S. Weinberg
SLSarah L. Laughon
Sarah L. Laughon
RCRebecca Carlson
Rebecca Carlson
JBJames R. Bateman
James R. Bateman
DRDonald L. Rosenstein
Donald L. Rosenstein

15 August 2020 in Journal of Neurotrauma
Verified
Journal Article
Closed access
JRJared Rowland
Jared Rowland
SMSarah L. Martindale
Sarah L. Martindale
RSRobert D. Shura
Robert D. Shura
HMHolly M. Miskey
Holly M. Miskey
JBJames R. Bateman
James R. Bateman
KTKatherine H. Taber
Katherine H. Taber
With the increasing prevalence of traumatic brain injury (TBI), the need for reliable and valid methods to evaluate TBI has also increased. The purpose of this study was to establish the validity and reliability of a new comprehensive assessment of TBI, the Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) Assessment of TBI (MMA-TBI). The participants in this study were post-deployment, combat exposed veterans. First, MMA-TBI outcomes were compared with those of independently conducted clinical TBI assessments. Next, MMA-TBI outcomes were compared with those of a different validated TBI measure (the Ohio State University TBI Identification method [OSU-TBI-ID]). Next, four TBI subject matter experts independently evaluated 64 potential TBI events based on both clinical judgment and Veterans Administration/Department of Defense (VA/DoD) Clinical Practice Guidelines. Results of the MMA-TBI algorithm (based on VA/DoD clinical guideline) were compared with those of the subject matter experts. Diagnostic correspondence with independently conducted expert clinical evaluation was 96% for lifetime TBI and 92% for deployment-acquired TBI. Consistency between the MMA-TBI and the OSU-TBI-ID was high (κ = 0.90; Kendall Tau = 0.94). Comparison of MMA-TBI algorithm results with those of subject matter experts was high (κ = 0.97–1.00). The MMA-TBI is the first TBI interview to be validated against an independently conducted clinical TBI assessment. Overall, results demonstrate the MMA-TBI is a highly valid and reliable instrument for determining TBI based on VA/DoD clinical guidelines. These results support the need for application of standardized TBI criteria across all diagnostic contexts.

1 January 2024 in The Journal of Neuropsychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
JBJames R. Bateman
James R. Bateman
MFMichael A. Ferguson
Michael A. Ferguson
CAC. Alan Anderson
C. Alan Anderson
DADavid B. Arciniegas
David B. Arciniegas
AGAsaf Gilboa
Asaf Gilboa
MFMichael D. Fox
Michael D. Fox

30 January 2024 in Archives of Clinical Neuropsychology
Verified
Journal Article
Open access
PDF file
BSBonnie C Sachs
Bonnie C Sachs
LLLauren A Latham
Lauren A Latham
JBJames R Bateman
James R Bateman
MCMary Jo Cleveland
Mary Jo Cleveland
MEMark A Espeland
Mark A Espeland
SCSuzanne Craft
Suzanne Craft
Assess the feasibility and concurrent validity of a modified Uniform Data Set version 3 (UDSv3) for remote administration for individuals with normal cognition (NC), mild cognitive impairment (MCI), and early dementia. Participants (N = 93) (age: 72.8 [8.9] years; education: 15.6 [2.5] years; 72% female; 84% White) were enrolled from the Wake Forest ADRC. Portions of the UDSv3 cognitive battery, plus the Rey Auditory Verbal Learning Test, were completed by telephone or video within ~6 months of participant’s in-person visit. Adaptations for phone administration (e.g., Oral Trails for Trail Making Test [TMT] and Blind Montreal Cognitive Assessment [MoCA] for MoCA) were made. Participants reported on the pleasantness, difficulty, and preference for each modality. Staff provided validity ratings for assessments. Participants’ remote data were adjudicated by cognitive experts blinded to the in person-diagnosis (NC [N = 44], MCI [N = 35], Dementia [N = 11], or other [N = 3]). Remote assessments were rated as pleasant as in-person assessments by 74% of participants and equally difficult by 75%. Staff validity rating (video = 92%; phone = 87.5%) was good. Concordance between remote/in-person scores was generally moderate to good (r = .3 −.8; p < .05) except for TMT-A/OTMT-A (r = .3; p > .05). Agreement between remote/in-person adjudicated cognitive status was good (k = .61–.64). We found preliminary evidence that older adults, including those with cognitive impairment, can be assessed remotely using a modified UDSv3 research battery. Adjudication of cognitive status that relies on remotely collected data is comparable to classifications using in-person assessments.